Followers
12
Following
4
Blog Posts
303
Threads
4,653
Blogs
Threads
Portfolio
Follower
Following
2020-09-02 14:38 | Report Abuse
SEE_Research Pharmaniaga /7081
D Pharma /7148
Already noticed FIRSTLY,
At 10.51am,
2 September 2020 and informed.
On technical charts, already showing weak hourly charts
Pls check out the
Pharmaniaga /7081
Still have opportunities to sell at
RM 5.49
RM 5.50
Closed 12.30pm,
2 September 2020
RM 5.43
( - RM 0.20)
Low at 12.30pm=RM 5.43
Low at 10.51am =RM 5.50
============================================
D Pharma /7148
At 10. 51am
RM 3.56
RM 3.57
At closed 12.30 pm
RM RM 3.54( - RM 0.11)
LOW RM 3.53
=============================%================
REMARKS
ON TECHNICAL CHARTS, CANNOT LIE,
MANY A TIMES, WORK LIKE A LIE DETECTOR,
YOU CAN CONFIRM WITH SOME OF YOUR FRIENDS WHO ARE GOOD IN READING IN TECHNICAL CHARTS, THEY WILL CONFIRM ON SUPPORT LINES,
RESISTANCES LEVEL
PLS PROTECT YOUR OWN PROFITS,
LATER,
THE PROFITS CAN BE DIMINISHED,
FINALLY, CAN TURN POTENTIAL LOSS,
PROTECTING PROFITS ARE THE NORMAL,
OPTIMUM
ULTIMATE ACTIONS TO TAKE.
AND IT IS THE MOST IMPORTANT CRITERIA TO INITIATE - -
[WHETHER BIG OR SMALL PROFITS].
DO NOT BE A SITTING BULL, OPENING ONE MONTH BIG, NOT KNOWING TO TAKE THIS MOST IMPORTANT ACTION.
PLS ALSO TAKE NOTICE,
THERE ARE LOUDSPEAKERS -
SHOUTING HUAT,
SHOUTING COMING
ARE THE REAL PEOPLE TO BE CAREFUL WITH,
AS SOME
(not ALL),
HAVE THEIR NEGATIVE INTENTIONS FOR THE INVESTORS TO PURCHASE HIGHER PRICES SO THAT THEY CAN UNLOAD THEIR EARLY PORTIONS OF THE RESPECTIVE PORTIONS
FOR YOU
(AS THEY HAVE COLLECTED EARLIER).
THE NEWBIES, ARE EXCITED AND LURE TO PURCHASE,
FINALLY,
THE NEWBIES HAVE
TO HOLD FOR A LONG TIME.
02/09/2020 1:12 PM
2020-09-02 13:16 | Report Abuse
SEE_Research Pharmaniaga /7081
D Pharma /7148
Already noticed FIRSTLY,
At 10.51am,
2 September 2020 and informed.
On technical charts, already showing weak hourly charts
Pls check out the
Pharmaniaga /7081
Still have opportunities to sell at
RM 5.49
RM 5.50
Closed 12.30pm,
2 September 2020
RM 5.43
( - RM 0.20)
Low at 12.30pm=RM 5.43
Low at 10.51am =RM 5.50
============================================
D Pharma /7148
At 10. 51am
RM 3.56
RM 3.57
At closed 12.30 pm
RM RM 3.54( - RM 0.11)
LOW RM 3.53
=============================%================
REMARKS
ON TECHNICAL CHARTS, CANNOT LIE,
MANY A TIMES, WORK LIKE A LIE DETECTOR,
YOU CAN CONFIRM WITH SOME OF YOUR FRIENDS WHO ARE GOOD IN READING IN TECHNICAL CHARTS, THEY WILL CONFIRM ON SUPPORT LINES,
RESISTANCES LEVEL
PLS PROTECT YOUR OWN PROFITS,
LATER,
THE PROFITS CAN BE DIMINISHED,
FINALLY, CAN TURN POTENTIAL LOSS,
PROTECTING PROFITS ARE THE NORMAL,
OPTIMUM
ULTIMATE ACTIONS TO TAKE.
AND IT IS THE MOST IMPORTANT CRITERIA TO INITIATE - -
[WHETHER BIG OR SMALL PROFITS].
DO NOT BE A SITTING BULL, OPENING ONE MONTH BIG, NOT KNOWING TO TAKE THIS MOST IMPORTANT ACTION.
PLS ALSO TAKE NOTICE,
THERE ARE LOUDSPEAKERS -
SHOUTING HUAT,
SHOUTING COMING
ARE THE REAL PEOPLE TO BE CAREFUL WITH,
AS SOME
(not ALL),
HAVE THEIR NEGATIVE INTENTIONS FOR THE INVESTORS TO PURCHASE HIGHER PRICES SO THAT THEY CAN UNLOAD THEIR EARLY PORTIONS OF THE RESPECTIVE PORTIONS
FOR YOU
(AS THEY HAVE COLLECTED EARLIER).
THE NEWBIES, ARE EXCITED AND LURE TO PURCHASE,
FINALLY,
THE NEWBIES HAVE
TO HOLD FOR A LONG TIME.
2020-09-02 13:12 | Report Abuse
Pharmaniaga /7081
D Pharma /7148
Already noticed FIRSTLY,
At 10.51am,
2 September 2020 and informed.
On technical charts, already showing weak hourly charts
Pls check out the
Pharmaniaga /7081
Still have opportunities to sell at
RM 5.49
RM 5.50
Closed 12.30pm,
2 September 2020
RM 5.43
( - RM 0.20)
Low at 12.30pm=RM 5.43
Low at 10.51am =RM 5.50
============================================
D Pharma /7148
At 10. 51am
RM 3.56
RM 3.57
At closed 12.30 pm
RM RM 3.54( - RM 0.11)
LOW RM 3.53
=============================%================
REMARKS
ON TECHNICAL CHARTS, CANNOT LIE,
MANY A TIMES, WORK LIKE A LIE DETECTOR,
YOU CAN CONFIRM WITH SOME OF YOUR FRIENDS WHO ARE GOOD IN READING IN TECHNICAL CHARTS, THEY WILL CONFIRM ON SUPPORT LINES,
RESISTANCES LEVEL
PLS PROTECT YOUR OWN PROFITS,
LATER,
THE PROFITS CAN BE DIMINISHED,
FINALLY, CAN TURN POTENTIAL LOSS,
PROTECTING PROFITS ARE THE NORMAL,
OPTIMUM
ULTIMATE ACTIONS TO TAKE.
AND IT IS THE MOST IMPORTANT CRITERIA TO INITIATE - -
[WHETHER BIG OR SMALL PROFITS].
DO NOT BE A SITTING BULL, OPENING ONE MONTH BIG, NOT KNOWING TO TAKE THIS MOST IMPORTANT ACTION.
PLS ALSO TAKE NOTICE,
THERE ARE LOUDSPEAKERS -
SHOUTING HUAT,
SHOUTING COMING
ARE THE REAL PEOPLE TO BE CAREFUL WITH,
AS SOME
(not ALL),
HAVE THEIR NEGATIVE INTENTIONS FOR THE INVESTORS TO PURCHASE HIGHER PRICES SO THAT THEY CAN UNLOAD THEIR EARLY PORTIONS OF THE RESPECTIVE PORTIONS
FOR YOU
(AS THEY HAVE COLLECTED EARLIER).
THE NEWBIES, ARE EXCITED AND LURE TO PURCHASE,
FINALLY,
THE NEWBIES HAVE
TO HOLD FOR A LONG TIME.
2020-09-02 12:16 | Report Abuse
SEE_Research Pharmaniaga /7081
D Pharma /7148
As at now - 12.10pm,
2 September 2020
On technical charts, both stocks are
SHOWING WEAK HOURLY CHARTS,
PLS PROTECT YOUR PROFITS,
THE PROFITS MAY BE DIMINISHED,
WORST TURN TO LOSSES
BOTH STOCKS ARE STRUGGLING
PHARMANIAGA,
LOW RM 5.45
D Pharma
LOW RM 3.54
Pls initiate your QUICK ACTIONS BEFORE THE CLOSING OF 2 SEPTEMBER 2020
02/09/2020 12:15 PM
2020-09-02 12:15 | Report Abuse
Pharmaniaga /7081
D Pharma /7148
As at now - 12.10pm,
2 September 2020
On technical charts, both stocks are
SHOWING WEAK HOURLY CHARTS,
PLS PROTECT YOUR PROFITS,
THE PROFITS MAY BE DIMINISHED,
WORST TURN TO LOSSES
BOTH STOCKS ARE STRUGGLING
PHARMANIAGA,
LOW RM 5.45
D Pharma
LOW RM 3.54
Pls initiate your QUICK ACTIONS BEFORE THE CLOSING OF 2 SEPTEMBER 2020
2020-09-02 11:57 | Report Abuse
SEE_Research Pharmaniaga /7081
D Pharma /7148
Now - 11.50am,
2 September 2020
On technical charts
These technical charts are showing on hourly weak,
Pls protect your profits,
Later by closing, the profits may be diminished,
and worst turn into some losses
02/09/2020 11:55 AM
2020-09-02 11:55 | Report Abuse
Pharmaniaga /7081
D Pharma /7148
Now - 11.50am,
2 September 2020
On technical charts
These technical charts are showing on hourly weak,
Pls protect your profits,
Later by closing, the profits may be diminished,
and worst turn into some losses
2020-09-02 11:42 | Report Abuse
SEE_Research D pharma / 7148
Pharmaniaga /7081
On technical charts,
It is good to lock on your profit,
Pls take profit from this weak down trends charts
As at now,
10.51am,
2 September 2020
(i) D Pharma /7148
RM 3.58
(-RM 0.07)
(ii) Pharmaniaga /7081
RM 5.51
(-RM 0.12)
02/09/2020 10:55 AM
2020-09-02 10:56 | Report Abuse
SEE_Research D pharma / 7148
Pharmaniaga /7081
On technical charts,
It is good to lock on your profit,
Pls take profit from this weak down trends charts
As at now,
10.51am,
2 September 2020
(i) D Pharma /7148
RM 3.58
(-RM 0.07)
(ii) Pharmaniaga /7081
RM 5.51
(-RM 0.12)
02/09/2020 10:55 AM
2020-09-02 10:55 | Report Abuse
D pharma / 7148
Pharmaniaga /7081
On technical charts,
It is good to lock on your profit,
Pls take profit from this weak down trends charts
As at now,
10.51am,
2 September 2020
(i) D Pharma /7148
RM 3.58
(-RM 0.07)
(ii) Pharmaniaga /7081
RM 5.51
(-RM 0.12)
2020-09-01 17:05 | Report Abuse
To :stockraider
When the investors intend to issue buy orders,
On vaccines,
After weighing the pros /cons
The selection whether preferences on these
2 pharmaceutical outlets, or
Solution /Cansino, needless to say they will choose your recommendation
2020-09-01 16:16 | Report Abuse
To :BALANCE_VIEW
You are fully right that, vaccines for storage purposes, requires hugh warehouse facilities with proper low temperature controlled,
DEFINITELY, BY BUYING SOME FRIDGES AND STORE INSIDE THE
DOMESTICS REFRIGERATORS,
THE VACCINE IN COMMERCIAL QUANTITIES
REALLY REQUIRE FULLY COMMERCIAL FACILITIES,
BOTH THESE PHARMA OUTLETS DO NOT HAVE SUCH FACILITIES,
EVEN THE HIGH GRADE PROFESSIONS IN THESE 2 PHARMA OUTLETS MAY ONLY CHEMIST'S,
NOT LIKE INTERNATIONAL ADVANCED PHARMACEUTICAL COMPANIES EMPLOYING HIGH END SCIENTISTS,
EVEN THE LOWEST OF THE TOP
8 PHARMACEUTICAL COMPANIES IN US,
Abbott Laboratories in their employees list,
have a great team of scientists.
2020-09-01 12:54 | Report Abuse
RHB downgrades Duopharma to 'sell' following overdose of vaccine hope
Areeshya Thevamanohar
/
theedgemarkets.com
July 29, 2020 10:43 am +08
-A+A
KUALA LUMPUR (July 29): RHB Investment Bank Research has downgraded its rating of Duopharma Biotech Bhd to “sell” at RM2.82, with an unchanged discounted cash flow (DCF)-derived target price (TP) of RM1.95 and 31% downside.
In a note today, RHB analyst Alan Lim said the downgrade followed a media report which stated that packaging of the prospective Covid-19 vaccine will not be exclusive to Duopharma and Pharmaniaga Bhd.
“We maintain our earnings estimates as we have not imputed any earnings contribution from the potential vaccine.
Sponsored Content
“Although the company is fundamentally strong, a valuation of +3.98SD (standard deviation) means its share price has run up purely on speculation. We expect no positive surprises for the second quarter ended on June 30, 2020 (2QFY20) and FY20F earnings,” he added.
Lim said the New Straits Times, quoting Science, Technology and Innovation Minister Khairy Jamaluddin, had reported that the selection of companies to package the Covid-19 vaccine (once it has been developed) will not be limited to Duopharma and Pharmaniaga.
He said this followed an initial report by theedgemarkets.com on July 14 that Duopharma and Pharmaniaga were selected to undertake the fill-and-finish processes of the Covid-19 vaccine.
Lim noted that Duopharma's share price had surged 76% in the past one month with no change in the company’s fundamentals.
“At RM2.82, Duopharma is trading at 30.5 times FY21F price-earnings ratio (PER). Although it is fundamentally strong, we believe that the huge premium is not justified in the absence of an immediate catalyst which would improve earnings significantly for the near term.
“We expect Duopharma to announce its 2QFY20 results in August. Earnings should match expectations with no major positive surprises."
Lim expects Vitamin C sales to be strong in 2QFY20.
However, he said sales of pharmaceutical products to private hospitals were likely to be weak due to a low occupancy rate.
With no surprises seen for 2QFY20, Lim said FY20F earnings growth is also limited at 6%.
At 9.42am, Duopharma had shed four sen or 1.42% to RM2.79, with a market capitalisation of RM1.93 billion. The stock saw some 4.7 million shares traded.
2020-09-01 12:52 | Report Abuse
RHB downgrades Duopharma to 'sell' following overdose of vaccine hope
Areeshya Thevamanohar
/
theedgemarkets.com
July 29, 2020 10:43 am +08
-A+A
KUALA LUMPUR (July 29): RHB Investment Bank Research has downgraded its rating of Duopharma Biotech Bhd to “sell” at RM2.82, with an unchanged discounted cash flow (DCF)-derived target price (TP) of RM1.95 and 31% downside.
In a note today, RHB analyst Alan Lim said the downgrade followed a media report which stated that packaging of the prospective Covid-19 vaccine will not be exclusive to Duopharma and Pharmaniaga Bhd.
“We maintain our earnings estimates as we have not imputed any earnings contribution from the potential vaccine.
Sponsored Content
“Although the company is fundamentally strong, a valuation of +3.98SD (standard deviation) means its share price has run up purely on speculation. We expect no positive surprises for the second quarter ended on June 30, 2020 (2QFY20) and FY20F earnings,” he added.
Lim said the New Straits Times, quoting Science, Technology and Innovation Minister Khairy Jamaluddin, had reported that the selection of companies to package the Covid-19 vaccine (once it has been developed) will not be limited to Duopharma and Pharmaniaga.
He said this followed an initial report by theedgemarkets.com on July 14 that Duopharma and Pharmaniaga were selected to undertake the fill-and-finish processes of the Covid-19 vaccine.
Lim noted that Duopharma's share price had surged 76% in the past one month with no change in the company’s fundamentals.
“At RM2.82, Duopharma is trading at 30.5 times FY21F price-earnings ratio (PER). Although it is fundamentally strong, we believe that the huge premium is not justified in the absence of an immediate catalyst which would improve earnings significantly for the near term.
“We expect Duopharma to announce its 2QFY20 results in August. Earnings should match expectations with no major positive surprises."
Lim expects Vitamin C sales to be strong in 2QFY20.
However, he said sales of pharmaceutical products to private hospitals were likely to be weak due to a low occupancy rate.
With no surprises seen for 2QFY20, Lim said FY20F earnings growth is also limited at 6%.
At 9.42am, Duopharma had shed four sen or 1.42% to RM2.79, with a market capitalisation of RM1.93 billion. The stock saw some 4.7 million shares traded.
2020-09-01 12:38 | Report Abuse
SEE_Research To :menort
To :BALANCE_VIEW
Full agreed on
Your remarks
(i) sales revenues,
on refilling or repacking are very limited, as the Malaysian government are inclined to be affordable to the citizens,
Anyway, it is just a projection with little or no concrete plans as without extensive logistics and storage facilities,
CANNOT PERFORM THIS REFILLING, REPACKING,
NOT THAT SIMPLE REFILLING ON BOTTLED DRINKS.
(ii) no concrete vaccine name,
no concrete official liaison with
ANY PRINCIPALS OF VACCINE INVENTORS
IN SHORT, AS RHB Bank research, there is no significant revenues in the near future to substantiate the prices run, purely on
SPECULATION and in fact downgrades
D Pharma to sell with target price
RM 1.95
RHB Bank further stated that this downgrade followed a media report which stated that the packaging of the PROSPECTIVE COVID 19 vaccine WILL NOT BE EXCLUSIVE TO
DUOPHARMA AND PHARMANIAGA BHD.
RHB RESEARCH EXPECT
NO POSITIVE SURPRISES FOR THE SECOND QUARTER AND FY20 EARNINGS.
THE FULL REPORT IS BY
THE EDGE MARKETS
ISSUED BY
Areeshya Thevamanohar
July 29, 2020
10.43am
Subject title :
RHB downgrades
Duopharma to "sell
2020-09-01 12:25 | Report Abuse
To :menort
To :BALANCE_VIEW
Full agreed on
Your remarks
(i) sales revenues,
on refilling or repacking are very limited, as the Malaysian government are inclined to be affordable to the citizens,
Anyway, it is just a projection with little or no concrete plans as without extensive logistics and storage facilities,
CANNOT PERFORM THIS REFILLING, REPACKING,
NOT THAT SIMPLE REFILLING ON BOTTLED DRINKS.
(ii) no concrete vaccine name,
no concrete official liaison with
ANY PRINCIPALS OF VACCINE INVENTORS
IN SHORT, AS RHB Bank research, there is no significant revenues in the near future to substantiate the prices run, purely on
SPECULATION and in fact downgrades
D Pharma to sell with target price
RM 1.95
RHB Bank further stated that this downgrade followed a media report which stated that the packaging of the PROSPECTIVE COVID 19 vaccine WILL NOT BE EXCLUSIVE TO
DUOPHARMA AND PHARMANIAGA BHD.
RHB RESEARCH EXPECT
NO POSITIVE SURPRISES FOR THE SECOND QUARTER AND FY20 EARNINGS.
THE FULL REPORT IS BY
THE EDGE MARKETS
ISSUED BY
Areeshya Thevamanohar
July 29, 2020
10.43am
Subject title :
RHB downgrades
Duopharma to "sell"
2020-08-31 19:24 | Report Abuse
Supermax /7106
The next list of Top Shareholders,
After 1 September 2020 onwards the whole list will consist of more than 80 %
outside financial funds, as
Supermax becomes more visible to foreign funds outside Malaysi
a as already included in
MSCI Index
Cheers for Supermax
2020-08-31 18:29 | Report Abuse
SEE_Research To :gemfinder
To :stockraider
To:tiger69, sudden appear from nowhere
To: all the small kids who believe in vaccine
======================================≠===========
Pharmaniaga /7081
D Pharma / 7148
It will be some helps to these 2
I3 investor forums
For you to approach as you all have higher opportunities to induce them on your vaccine story,
also you have higher chances to introduce your vaccine counters around the prices of
RM 1.00 and below
You are wasting
ALL YOUR TIME AND FRUITLESS EFFORTS HERE,
IF YOU STILL DO NOT UNDERSTAND,
THEN YOU CAN LEARN MORE ABOUT MARKETING SEGMENTS
YOUR COUNTERS ARE INCLINED TO
RM 1.00 and below,
Whereas you are engaging with the more bigger boys.
We do not want to sound RUDE
In short, the kindergarten small kids running aimlessly, trying to kick goals whilst playing with the real time
Liverpool,
Premium Class Football
2020-08-31 16:36 | Report Abuse
To :gemfinder
To :stockraider
To: all the small kids who believe in vaccine
======================================≠===========
Pharmaniaga /7081
D Pharma / 7148
It will be some helps to these 2
I3 investor forums
For you to approach as you all have higher opportunities to induce them on your vaccine story,
also you have higher chances to introduce your vaccine counters around the prices of
RM 1.00 and below
You are wasting
ALL YOUR TIME AND FRUITLESS EFFORTS HERE,
IF YOU STILL DO NOT UNDERSTAND,
THEN YOU CAN LEARN MORE ABOUT MARKETING SEGMENTS
YOUR COUNTERS ARE INCLINED TO
RM 1.00 and below,
Whereas you are engaging with the more bigger boys.
We do not want to sound RUDE
In short, the kindergarten small kids running aimlessly, trying to kick goals whilst playing with the real time
Liverpool,
Premium Class Football
Stock: [DPHARMA]: DUOPHARMA BIOTECH BERHAD
2020-09-02 14:40 | Report Abuse
SEE_Research SEE_Research Pharmaniaga /7081
D Pharma /7148
Already noticed FIRSTLY,
At 10.51am,
2 September 2020 and informed.
On technical charts, already showing weak hourly charts
Pls check out the
Pharmaniaga /7081
Still have opportunities to sell at
RM 5.49
RM 5.50
Closed 12.30pm,
2 September 2020
RM 5.43
( - RM 0.20)
Low at 12.30pm=RM 5.43
Low at 10.51am =RM 5.50
============================================
D Pharma /7148
At 10. 51am
RM 3.56
RM 3.57
At closed 12.30 pm
RM RM 3.54( - RM 0.11)
LOW RM 3.53
=============================%================
REMARKS
ON TECHNICAL CHARTS, CANNOT LIE,
MANY A TIMES, WORK LIKE A LIE DETECTOR,
YOU CAN CONFIRM WITH SOME OF YOUR FRIENDS WHO ARE GOOD IN READING IN TECHNICAL CHARTS, THEY WILL CONFIRM ON SUPPORT LINES,
RESISTANCES LEVEL
PLS PROTECT YOUR OWN PROFITS,
LATER,
THE PROFITS CAN BE DIMINISHED,
FINALLY, CAN TURN POTENTIAL LOSS,
PROTECTING PROFITS ARE THE NORMAL,
OPTIMUM
ULTIMATE ACTIONS TO TAKE.
AND IT IS THE MOST IMPORTANT CRITERIA TO INITIATE - -
[WHETHER BIG OR SMALL PROFITS].
DO NOT BE A SITTING BULL, OPENING ONE MONTH BIG, NOT KNOWING TO TAKE THIS MOST IMPORTANT ACTION.
PLS ALSO TAKE NOTICE,
THERE ARE LOUDSPEAKERS -
SHOUTING HUAT,
SHOUTING COMING
ARE THE REAL PEOPLE TO BE CAREFUL WITH,
AS SOME
(not ALL),
HAVE THEIR NEGATIVE INTENTIONS FOR THE INVESTORS TO PURCHASE HIGHER PRICES SO THAT THEY CAN UNLOAD THEIR EARLY PORTIONS OF THE RESPECTIVE PORTIONS
FOR YOU
(AS THEY HAVE COLLECTED EARLIER).
THE NEWBIES, ARE EXCITED AND LURE TO PURCHASE,
FINALLY,
THE NEWBIES HAVE
TO HOLD FOR A LONG TIME.
02/09/2020 1:12 PM
02/09/2020 2:38 PM